Middle East and Africa Dermal Fillers Market Developments and Forecast by 2028

Middle East and Africa Dermal Fillers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Biodegradable and Non-Biodegradable), Material [Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate (PMMA), Fat Fillers, and Other Materials], Application (Facial Line Correction Treatment, Lip Enhancement, Face Lift, Scar Treatment, and Others), and End user (Multispecialty Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, and Other End Users)

Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028
  • Status : Published
  • Report Code : TIPRE00025314
  • Category : Life Sciences
  • No. of Pages : 140
  • Available Report Formats : pdf-format excel-format
  • Last update date : October 11, 2021
Middle East and Africa Dermal Fillers Market Developments and Forecast by 2028
Report Date: October 11, 2021   |   Report Code: TIPRE00025314 Email: sales@theinsightpartners.com

2021 Market Size

US$ 186.54 Mn

Base year value

2028 Forecast

US$ 370.50 Mn

Projected by 2028

CAGR 2022-2028

10.3 %

Growth rate

Addressable Market

US$ 1,970.09 Mn

(2022-2028)

The Middle East and Africa dermal fillers market is expected to reach US$ 370.50 million by 2028 from US$ 186.54 million in 2021; it is estimated to grow with a CAGR of 10.3% from 2021 to 2028.



The growth of the market is attributed to the factors such as preference for minimally invasive procedures, growth in population of age 30–65 years, and rise in the attraction of consumers toward beauty and wellness. However, the high cost of surgeries hinders the market growth.

People from the age group 30–65, struggling with the signs of aging such as lack of skin elasticity, wrinkles, and dark spots, are the major target of the dermal filler market players. Women of age 40–54 are the prime adopters of get dermal filler treatments. The younger age brackets make up a much smaller portion of the population pursuing dermal fillers.  Also, long work hours and changing lifestyle have contributed significantly to rising levels of stress, resulting in several issues on the exterior appearance, especially on the skin and hair. Also, the increasing level of pollution shows detrimental effects on an individual’s physical appearance. Thus, international grooming products and at-home services have gained popularity to a great extent. Shifting focus on appearance has significantly increased the demand for beauty and dermatology products across the world. Premium beauty brands are now offering additional services, such as skin diagnosis, at their outlets to attract customers. Furthermore, the number of specialty skin clinics offering target treatments for various skin issues has also ramped up in recent years. In addition, the beauty industry is growing rapidly as the millennial women, of aged 25–34, are increasingly purchasing cosmetic products. Thus, the increasing acceptance of beauty devices and products among both men and women is likely to be a prevalent trend in the Europe dermal fillers market in the coming years.

Countries in the Middle East witnessed considerable growth in the number of COVID-19 cases in 2020. While many industries have been adversely affected by the pandemic, the cosmetic industry in this region witnessed a steady demand. Cosmetic clinics in the UAE have been adhering to all of the necessary regulations set by their authorities, such as routine cleaning and regular COVID-19 testing of employees, to ensure safety of employees and clients, among others. However, the dermal fillers market players recorded reduced demand for cosmetic treatments during the pandemic. The healthcare sectors in the Middle East and African countries mainly focused on the treatment and diagnosis of COVID-19 patients, which resulted in the delays of cancellation of appointments for the dermatological surgeries. In January 2021, Dubai Health Authority directed all licensed hospitals and one-day surgery clinics to suspend all nonurgent surgical procedures. Thus, the dermal fillers market Middle East and Africa experienced moderate impact of the COVID-19 pandemic.

24923-img1
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
 

MIDDLE EAST AND AFRICA DERMAL FILLERS MARKET SEGMENTATION

By Product

  • Biodegradable
  • Non-Biodegradable

By Material

  • Calcium Hydroxylapatite
  • Hyaluronic Acid
  • Collagen
  • Poly-L-Lactic Acid
  • Polymethylmethacrylate (PMMA)
  • Fat Fillers
  • Other

By Application

  • Facial Line Correction Treatment
  • Lip Enhancement
  • Face Lift
  • Scar Treatment
  • Others

By End User

  • Dermatology Clinics
  • Multispecialty Hospitals
  • Ambulatory Surgical Centers
  • Others

By Country

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Company Profiles

  • AbbVie Inc.
  • Galderma
  • Merz Pharma
  • Suneva Medical
  • HUADONG MEDICINE CO., LTD
  • TEOXANE LABORATORIES
  • Prollenium Medical Technologies

Middle East and Africa Dermal Fillers Report Scope

Report Attribute Details
Market size in 2021 US$ 186.54 Million
Market Size by 2028 US$ 370.50 Million
CAGR (2021 - 2028) 10.3%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Biodegradable and Non-Biodegradable
By Material
  • Calcium Hydroxylapatite
  • Hyaluronic Acid
  • Collagen
  • Poly-L-Lactic Acid
  • Polymethylmethacrylate
  • Fat Fillers
  • Other Materials
By Application
  • Facial Line Correction Treatment
  • Lip Enhancement
  • Face Lift
  • Scar Treatment
By End user
  • Multispecialty Hospitals
  • Dermatology Clinics
  • Ambulatory Surgical Centers
  • Other End Users
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AbbVie Inc.
  • Galderma
  • Merz Pharma
  • Suneva Medical
  • HUADONG MEDICINE CO., LTD
  • TEOXANE LABORATORIES
  • Prollenium Medical Technologies
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA